Michael Su

10.4k total citations · 4 hit papers
50 papers, 8.8k citations indexed

About

Michael Su is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michael Su has authored 50 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Oncology. Recurrent topics in Michael Su's work include Cell death mechanisms and regulation (9 papers), Melanoma and MAPK Pathways (8 papers) and Acute Myeloid Leukemia Research (7 papers). Michael Su is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Melanoma and MAPK Pathways (8 papers) and Acute Myeloid Leukemia Research (7 papers). Michael Su collaborates with scholars based in United States, Japan and France. Michael Su's co-authors include Keisuke Kuida, Richard A. Flavell, Yong Gu, David J. Livingston, Matthew W. Harding, George Ku, Judith A. Lippke, Pasko Rakić, Tarik F. Haydar and Chia‐Yi Kuan and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Su

49 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme

1995 1.4k citations Keisuke Kuida, Judith A. Lippke et al. profile →
Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9

1998 1.4k citations Keisuke Kuida, Tarik F. Haydar et al. Cell profile →
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme

1997 996 citations Yong Gu, Keisuke Kuida et al. profile →
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

2004 782 citations Elizabeth A. Harrington, David Bebbington et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Su United States	32	6.4k	2.6k	1.4k	1.1k	884	50	8.8k
Christian Rommel United States	44	7.3k 1.1×	2.1k 0.8×	1.7k 1.2×	1.0k 0.9×	516 0.6×	88	10.2k
Joseph T. Opferman United States	43	6.0k 0.9×	2.6k 1.0×	1.5k 1.0×	1.2k 1.1×	1.9k 2.2×	95	9.5k
Hamsa Puthalakath Australia	32	4.8k 0.8×	2.0k 0.8×	1.2k 0.9×	1.5k 1.3×	1.2k 1.3×	65	7.2k
Silvano Capitani Italy	51	4.8k 0.7×	1.6k 0.6×	1.3k 0.9×	813 0.7×	737 0.8×	262	7.9k
Paul G. Ekert Australia	41	5.9k 0.9×	1.7k 0.6×	1.3k 0.9×	620 0.5×	1.3k 1.4×	128	8.3k
Raymond B. Birge United States	47	3.6k 0.6×	3.2k 1.2×	1.1k 0.8×	1.0k 0.9×	502 0.6×	112	7.6k
Tak W. Mak Canada	32	5.6k 0.9×	2.3k 0.9×	1.3k 0.9×	810 0.7×	859 1.0×	44	8.1k
Andreas Villunger Austria	55	7.5k 1.2×	2.8k 1.1×	3.1k 2.1×	1.2k 1.0×	1.0k 1.1×	183	10.7k
Roberto Testi Italy	47	4.2k 0.7×	3.0k 1.1×	795 0.6×	704 0.6×	600 0.7×	113	7.4k
Xosé R. Bustelo Spain	57	7.0k 1.1×	2.8k 1.1×	2.0k 1.4×	1.9k 1.7×	382 0.4×	172	11.1k

Countries citing papers authored by Michael Su

Since Specialization

Citations

This map shows the geographic impact of Michael Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Su more than expected).

Fields of papers citing papers by Michael Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Su. The network helps show where Michael Su may publish in the future.

Co-authorship network of co-authors of Michael Su

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Su. A scholar is included among the top collaborators of Michael Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Su. Michael Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Kevin X., et al.. (2025). NETosis-specific cell death: a novel mechanism in the pathogenesis of gouty arthritis. European journal of medical research. 30(1). 1134–1134.

Geoerger, Birgit, Manuel Schiff, Virginie Penard‐Lacronique, et al.. (2023). Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation. Nature Medicine. 29(6). 1358–1363. 5 indexed citations

Su, Michael, Xuejun Zhu, & Wenjun Zhang. (2018). Probing the acyl carrier protein–Enzyme interactions within terminal alkyne biosynthetic machinery. AIChE Journal. 64(12). 4255–4262. 10 indexed citations

Zhu, Xuejun, Peyton Shieh, Michael Su, Carolyn R. Bertozzi, & Wenjun Zhang. (2016). A fluorogenic screening platform enables directed evolution of an alkyne biosynthetic tool. Chemical Communications. 52(75). 11239–11242. 16 indexed citations

Wang, Fang, Jeremy Travins, Yue Chen, et al.. (2014). Abstract 3116: AG-221 offers a survival advantage in a primary human IDH2 mutant AML xenograft model. Cancer Research. 74(19_Supplement). 3116–3116. 6 indexed citations

Hansen, Erica, Cyril Quivoron, René M. Lemieux, et al.. (2014). AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo. Blood. 124(21). 3734–3734. 40 indexed citations

Davis, Mindy I., Rajan Pragani, Janeta Popovici-Müller, et al.. (2013). ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells. Europe PMC (PubMed Central). 16 indexed citations

Yen, Katharine, René M. Lemieux, Janeta Popovici-Müller, et al.. (2013). IDH1 Mutant Inhibitor Induces Cellular Differentiation and Offers a Combination Benefit With Ara-C In a Primary Human Idh1 Mutant AML Xenograft Model. Blood. 122(21). 3946–3946. 13 indexed citations

Harrington, Elizabeth A., David Bebbington, Jeffrey R. Moore, et al.. (2004). VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature Medicine. 10(3). 262–267. 782 indexed citations breakdown →

10.

Ramanathan, Mathura P., et al.. (2002). Carboxyl Terminus of hVIP/mov34 Is Critical for HIV-1-Vpr Interaction and Glucocorticoid-mediated Signaling. Journal of Biological Chemistry. 277(49). 47854–47860. 23 indexed citations

11.

Fox, Ted, et al.. (1999). Kinetic mechanism and ATP‐binding site reactivity of p38γ MAP kinase. FEBS Letters. 461(3). 323–328. 25 indexed citations

12.

Kuida, Keisuke, Tarik F. Haydar, Chia‐Yi Kuan, et al.. (1998). Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9. Cell. 94(3). 325–337. 1369 indexed citations breakdown →

13.

Lin, Chien‐Ju, et al.. (1997). The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. Journal of Virology. 71(9). 6465–6471. 86 indexed citations

14.

Wilson, Keith P., Patricia G. McCaffrey, Kathy Hsiao, et al.. (1997). The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chemistry & Biology. 4(6). 423–431. 239 indexed citations

15.

Akita, Kenji, Takashi Ohtsuki, Tadao Tanimoto, et al.. (1997). Involvement of Caspase-1 and Caspase-3 in the Production and Processing of Mature Human Interleukin 18 in Monocytic THP.1 Cells. Journal of Biological Chemistry. 272(42). 26595–26603. 179 indexed citations

16.

Lippke, Judith A., et al.. (1996). Identification and Characterization of CPP32/Mch2 Homolog 1, a Novel Cysteine Protease Similar to CPP32. Journal of Biological Chemistry. 271(4). 1825–1828. 203 indexed citations

17.

Wilson, Keith P., Matthew J. Fitzgibbon, Paul R. Caron, et al.. (1996). Crystal Structure of p38 Mitogen-activated Protein Kinase. Journal of Biological Chemistry. 271(44). 27696–27700. 202 indexed citations

18.

Kawamura, Akinori & Michael Su. (1995). Interaction of FKBP12-FK506 with Calcineurin A at the B Subunit-binding Domain. Journal of Biological Chemistry. 270(26). 15463–15466. 41 indexed citations

19.

Gu, Yong, et al.. (1995). Cleavage of Poly(ADP-ribose) Polymerase by Interleukin-1β Converting Enzyme and Its Homologs TX and Nedd-2. Journal of Biological Chemistry. 270(32). 18715–18718. 145 indexed citations

20.

Milan, David J., et al.. (1994). The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell. 79(3). 437–447. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact